71 related articles for article (PubMed ID: 2548146)
1. In situ and in vitro evidence for intragenic binding of nuclear factors at the murine c-myc locus.
Tourkine N; Mechti N; Piechaczyk M; Jeanteur P; Blanchard JM
Oncogene; 1989 Aug; 4(8):973-8. PubMed ID: 2548146
[TBL] [Abstract][Full Text] [Related]
2. Altered myc gene transcription and intron-induced stabilization of myc RNAs in two mouse plasmacytomas.
Bauer SR; Piechaczyk M; Nordan RP; Owens JD; Nepveu A; Marcu KB; Mushinski JF
Oncogene; 1989 May; 4(5):615-23. PubMed ID: 2657576
[TBL] [Abstract][Full Text] [Related]
3. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
Roussel MF; Davis JN; Cleveland JL; Ghysdael J; Hiebert SW
Oncogene; 1994 Feb; 9(2):405-15. PubMed ID: 8290253
[TBL] [Abstract][Full Text] [Related]
4. c-myc and c-fos gene regulation during mouse liver regeneration.
Sobczak J; Mechti N; Tournier MF; Blanchard JM; Duguet M
Oncogene; 1989 Dec; 4(12):1503-8. PubMed ID: 2512526
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
Suhasini M; Boss GR; Pascual FE; Pilz RB
Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
[TBL] [Abstract][Full Text] [Related]
6. The block of elongation in c-myc exon 1 is abolished in Burkitt's lymphoma cell lines with variant translocation.
Eick D; Polack A; Kofler E; Bornkamm GW
Oncogene; 1988 Oct; 3(4):397-403. PubMed ID: 3078949
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific post-transcriptional regulation of c-myc expression in normal and H-2K/human c-myc transgenic mice.
Morello D; Asselin C; Lavenu A; Marcu KB; Babinet C
Oncogene; 1989 Aug; 4(8):955-61. PubMed ID: 2668846
[TBL] [Abstract][Full Text] [Related]
8. Two transient increases in c-myc gene expression during neuroectodermal differentiation of mouse embryonal carcinoma cells.
St-Arnaud R; Nepveu A; Marcu KB; McBurney MW
Oncogene; 1988 Nov; 3(5):553-9. PubMed ID: 3078960
[TBL] [Abstract][Full Text] [Related]
9. Expression of cellular oncogenes: unrearranged c-myc gene but altered promoter usage in radiation-induced thymoma.
Bandyopadhyay SK; D'Andrea E; Fleissner E
Oncogene Res; 1989; 4(4):311-8. PubMed ID: 2475843
[TBL] [Abstract][Full Text] [Related]
10. Elevated expression of c-myc and N-myc produces distinct changes in nuclear fine structure and chromatin organization.
Henriksson M; Classon M; Ingvarsson S; Koskinen P; Sümegi J; Klein G; Thyberg J
Oncogene; 1988 Nov; 3(5):587-93. PubMed ID: 3078963
[TBL] [Abstract][Full Text] [Related]
11. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells.
Bentley DL; Groudine M
Nature; 1986 Jun 12-18; 321(6071):702-6. PubMed ID: 3520340
[TBL] [Abstract][Full Text] [Related]
12. Studies of c-myb gene regulation in MRL-lpr/lpr mice. Identification of a 5' c-myb nuclear protein binding site and high levels of binding factors in nuclear extracts of lpr/lpr lymph node cells.
Mountz JD; Steinberg AD
J Immunol; 1989 Jan; 142(1):328-35. PubMed ID: 2642505
[TBL] [Abstract][Full Text] [Related]
13. Identification of a second promoter in the human c-myb proto-oncogene.
Jacobs SM; Gorse KM; Westin EH
Oncogene; 1994 Jan; 9(1):227-35. PubMed ID: 8302584
[TBL] [Abstract][Full Text] [Related]
14. Mode of c-myc gene regulation in folic acid-induced kidney regeneration.
Asselin C; Marcu KB
Oncogene Res; 1989; 5(1):67-72. PubMed ID: 2476708
[TBL] [Abstract][Full Text] [Related]
15. Evolutionary conservation of the product of human c-myc exon 1 and its inducible expression in a murine cell line.
Dedieu JF; Gazin C; Rigolet M; Galibert F
Oncogene; 1988 Nov; 3(5):523-9. PubMed ID: 3078958
[TBL] [Abstract][Full Text] [Related]
16. ECA39 is regulated by c-Myc in human and by a Jun/Fos homolog, Gcn4, in yeast.
Ben-Yosef T; Yanuka O; Benvenisty N
Oncogene; 1996 Nov; 13(9):1859-66. PubMed ID: 8934531
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation in megakaryocytes: the thrombopoietin receptor gene as a model.
Mignotte V; Deveaux S; Filipe A
Stem Cells; 1996; 14 Suppl 1():232-9. PubMed ID: 11012226
[TBL] [Abstract][Full Text] [Related]
18. The GATA-1 and Spi-1 transcriptional factors bind to a GATA/EBS dual element in the Fli-1 exon 1.
Barbeau B; Barat C; Bergeron D; Rassart E
Oncogene; 1999 Sep; 18(40):5535-45. PubMed ID: 10523830
[TBL] [Abstract][Full Text] [Related]
19. Regulation of the proto-oncogenes bcl-2 and c-myc by the Wilms' tumor suppressor gene WT1.
Hewitt SM; Hamada S; McDonnell TJ; Rauscher FJ; Saunders GF
Cancer Res; 1995 Nov; 55(22):5386-9. PubMed ID: 7585606
[TBL] [Abstract][Full Text] [Related]
20. Coexistence of a c-myc mRNA initiated in intron 1 with the normal c-myc mRNA and similar regulation of both transcripts in mammalian cells.
Ray D; Robert-Lézénès J
Oncogene Res; 1989; 5(1):73-8. PubMed ID: 2674860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]